AMRN — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

2.16

Margin Of Safety %

-25

Put/Call OI Ratio

0.23

EPS Next Q Diff

0.16

EPS Last/This Y

2.58

EPS This/Next Y

0.39

Price

14.74

Target Price

Analyst Recom

Performance Q

5.35

Upside

-545.2%

Beta

0.9

Ticker: AMRN

16 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-11	AMRN	16.34	0.22	0.00	4049
2026-03-12	AMRN	16.28	0.21	0.05	4164
2026-03-13	AMRN	16.37	0.21	0.05	4164
2026-03-17	AMRN	15.52	0.21	0.00	4193
2026-03-18	AMRN	14.95	0.21	0.00	4190
2026-03-20	AMRN	14.49	0.20	0.28	4419
2026-03-25	AMRN	14.72	0.31	0.13	2166
2026-03-26	AMRN	14.65	0.29	0.23	2382
2026-03-27	AMRN	14.44	0.28	0.63	2540
2026-03-30	AMRN	13.88	0.29	0.11	2555
2026-03-31	AMRN	14.44	0.27	0.07	2620
2026-04-01	AMRN	14.64	0.25	0.03	2912
2026-04-06	AMRN	14.59	0.24	0.00	3074
2026-04-07	AMRN	14.58	0.23	0.09	3100
2026-04-08	AMRN	14.67	0.23	0.24	3123
2026-04-09	AMRN	14.73	0.23	1.88	3177
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

16 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-11	AMRN	16.29	142.5	-	0.78
2026-03-12	AMRN	16.28	142.5	-	0.78
2026-03-13	AMRN	15.33	142.5	-	0.78
2026-03-17	AMRN	15.46	142.5	-	0.78
2026-03-18	AMRN	14.94	142.5	-	0.78
2026-03-19	AMRN	14.95	142.5	-	0.78
2026-03-20	AMRN	14.48	142.5	-	0.78
2026-03-23	AMRN	14.78	142.5	-	0.78
2026-03-24	AMRN	14.47	142.5	-	0.78
2026-03-25	AMRN	14.62	142.5	-	0.78
2026-03-26	AMRN	14.60	142.5	-	0.78
2026-03-27	AMRN	14.32	142.5	-	0.78
2026-03-30	AMRN	13.94	142.5	-	0.78
2026-03-31	AMRN	14.32	142.5	-	0.78
2026-04-01	AMRN	14.64	142.5	-	0.78
2026-04-02	AMRN	14.71	142.5	-	0.78
2026-04-06	AMRN	14.59	142.5	-	0.78
2026-04-07	AMRN	14.58	142.5	-	0.78
2026-04-08	AMRN	14.63	142.5	-	0.78
2026-04-09	AMRN	14.74	142.5	-	0.78
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-11	AMRN	0.00	-0.01	2.11
2026-03-12	AMRN	0.00	-0.01	2.11
2026-03-13	AMRN	0.00	-0.01	2.11
2026-03-18	AMRN	0.00	0.02	2.11
2026-03-19	AMRN	0.00	0.02	2.11
2026-03-20	AMRN	0.00	0.02	2.11
2026-03-23	AMRN	0.00	0.02	2.11
2026-03-24	AMRN	0.00	0.02	2.11
2026-03-25	AMRN	0.00	0.02	2.16
2026-03-26	AMRN	0.00	0.02	2.16
2026-03-27	AMRN	0.00	0.02	2.16
2026-03-30	AMRN	0.00	0.02	2.16
2026-03-31	AMRN	0.00	0.02	2.16
2026-04-01	AMRN	0.00	0.02	2.16
2026-04-02	AMRN	0.00	0.02	2.16
2026-04-06	AMRN	0.00	0.02	2.16
2026-04-07	AMRN	0.00	0.02	2.16
2026-04-08	AMRN	0.00	0.02	2.16
2026-04-09	AMRN	0.00	0.02	2.16
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.01

Avg. EPS Est. Current Quarter

0.17

Avg. EPS Est. Next Quarter

0.17

Insider Transactions

Institutional Transactions

0.02

Beta

0.9

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

11.02

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

87.7

Max Drawdown 5-Year %

-93.3

Target Price

P/E

Forward P/E

268.73

PEG

P/S

1.44

P/B

0.67

P/Free Cash Flow

EPS

-1.88

Average EPS Est. Cur. Y

0.78

EPS Next Y. (Est.)

1.17

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-18.19

Relative Volume

0.81

Return on Equity vs Sector %

-35.8

Return on Equity vs Industry %

-45.4

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.19

EBIT Estimation

◆ AMRN Healthcare

$14.78

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

23/25

Volume

7/15

Valuation

7/20

TP/AR

0/10

Options

7/10

RSI

50.2

Range 1M

33.5%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

22/30

Estimates

1/20

Inst/Vol

4/15

Options

5/10

EPS Yr

133.3%

EPS NY

83.3%

52W%

51.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +77.2% upside

Quality

5/30

Valuation

16/30

Growth

19/25

Stability

7/10

LT Trend

0/5

Upside

+77.2%

Quality

MoS

-25%

Amarin Corporation plc

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 80

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

AMRN

Latest News

—

Caricamento notizie per AMRN…

stock quote shares AMRN – Amarin Corp ADR Stock Price stock today

news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch AMRN – Amarin Corp ADR yahoo finance google finance

stock history AMRN – Amarin Corp ADR invest stock market

stock prices AMRN premarket after hours

ticker AMRN fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: AMRN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y